Search for: "E.I. DUPONT DE NEMOURS "
Results 181 - 200
of 211
Sorted by Relevance
|
Sort by Date
12 Oct 2017, 7:36 am
DuPont de Nemours & Co. v. [read post]
5 Sep 2016, 6:46 pm
DuPont de Nemours & Company, No. 15-1499 (is proof of a “reasonable expectation of success” necessary to combine references in an obviousness case against a claimed combination invention) Laches: Medinol Ltd. v. [read post]
5 Jul 2009, 3:31 pm
July 3, 2009 - Opinions ReleasedTEXAS SUPREME COURT ORDERS JUDGES TO EXPLAIN AND JUSTIFY WHY THEY GRANTED NEW TRIALS [in cases in which tort claim defendants had prevailed with the jury]"In the Interest of Justice" - a common label for judicial discretion in that regard and in others - will no longer pass muster as a sufficient ground. [read post]
24 May 2007, 10:40 am
DuPont De Nemours & Co., 868 P.2d 1114, 1121 (Colo. [read post]
28 Sep 2016, 8:39 am
DuPont de Nemours & Company, No. 15-1499 (is proof of a “reasonable expectation of success” necessary to combine references in an obviousness case against a claimed combination invention) Patent Attorney Malpractice: Encyclopaedia Britannica v. [read post]
4 Jul 2018, 4:58 pm
DuPont de Nemours & Co., 26 A.3d 162 (Del. 2011), and Riedel v. [read post]
14 Nov 2016, 9:16 am
by Dennis Crouch Substantive Patent Law: Newly filed petition in Merck & Cie v. [read post]
16 Jan 2017, 5:44 pm
by Dennis Crouch A new Supreme Court justice will likely be in place by the end of April, although the Trump edition is unlikely to substantially shake-up patent law doctrine in the short term. [read post]
28 Dec 2017, 11:10 am
Du Pont de Nemours, Louisville Works, 346 NLRB No. 113 (2016) and clarified that an employer does not have an affirmative duty to bargain over employment actions that are consistent with its past practice. [read post]
13 Oct 2016, 6:50 am
DuPont de Nemours & Company, No. 15-1499 (is proof of a “reasonable expectation of success” necessary to combine references in an obviousness case against a claimed combination invention) Jurisdiction: GeoTag, Inc. v. [read post]
13 May 2011, 6:07 pm
E.I. du Pont de Nemours & Co., 636 F.3d 88 (4th Cir. 2011), is an example. [read post]
19 Mar 2015, 4:57 pm
(D.I. 598; D.I. 610) Butamax and DuPont also filed a motion to exclude testimony by Gevo's experts with respect to the '188 patent and '376 patent. [read post]
25 Jun 2018, 5:39 pm
DuPont de Nemours and Co. v. [read post]
15 Apr 2009, 4:44 am
A.I. duPont Hospital for Children, ___ F. [read post]
29 Mar 2021, 7:10 pm
Some notes on vexing issue, which fortunately has never serious issue for me. [read post]
19 Nov 2009, 10:51 am
We aren't the first to note the latest class action denial in the prescription medical product liability field, In re Panacryl Sutures Products Liability Cases, No. 5:08-MD-1959-BO, slip op. [read post]
14 May 2012, 8:24 am
Sometimes legal counsel take positions in court determined solely by the expediency of what expert witnesses are available, and what opinions are held by those witnesses. [read post]
29 May 2016, 9:38 am
The Heart of the Matter The classic early cases in products liability law were about consumers hurt by consumer products, sold by manufacturers or dealers directly to consumers. [read post]
19 Jul 2007, 1:47 pm
We're so used to adverse decisions out of the District of Minnesota - what with the defibrillator MDLs "distinguishing" Buckman into near oblivion, and the heart valve MDL persisting in certifying classes despite being told not to by the Eighth Circuit - that good news from that district is like a breath of fresh air.That's what we got recently in In re Baycol Products Litigation, 2007 WL 2004432 (D. [read post]
5 Jul 2013, 5:00 am
If somebody were to ask us whether as a general proposition it’s relevant to the presentation of a product liability case about a prescription medical product that the FDA had approved/cleared the product and the defendant had complied with FDA regulations, our immediate reaction would be “Duh, of course, it’s relevant. [read post]
